The president of the Australian Medical Association, Dr Omar Khurshid, says lockdown measures are unlikely to contain a delta outbreak in NSW, urging the Australian Technical Advisory Group on Immunization (Atagi) to recommend the AstraZeneca vaccine for more age groups.
Currently, Atagi’s advice recommends Pfizer’s vaccine, which is in short supply and high in demand in Australia, “as the vaccine of choice for those aged 16 to under 60” due to the risk of a rare but severe thrombosis known as TTS associated with AstraZeneca. It is more common in the under 60 age group.
Khorshid said the advice had to be changed given the increasing number of infections in NSW, with an alarming number of people in the community, including in workplaces and supermarkets, while they were contagious. During her daily update on Friday, New South Wales Premier Gladys Berejiklian said vaccination would now be key to containing the outbreak and getting out of lockdown.